Managing murine food allergy with Cissampelos sympodialis Eichl (Menispermaceae) and its alkaloids  by Costa, Hermann Ferreira et al.
International Immunopharmacology 17 (2013) 300–308
Contents lists available at ScienceDirect
International Immunopharmacology
j ourna l homepage: www.e lsev ie r .com/ locate / in t impManaging murine food allergy with Cissampelos sympodialis Eichl
(Menispermaceae) and its alkaloidsHermann Ferreira Costa a, Fagner Carvalho Leite a,b, Adriano Francisco Alves a, José Maria Barbosa-Filho b,
Claudio Roberto Bezerra dos Santos a, Marcia Regina Piuvezam a,b,⁎
a Universidade Federal da Paraíba, Departamento de Fisiologia e Patologia, Laboratório de Imunofarmacologia, João Pessoa, Paraíba, Brazil
b Universidade Federal da Paraíba, Centro de Ciências da Saúde, Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos João Pessoa, Paraíba, Brazil⁎ Corresponding author at: Laboratório de Imunofarm
da Paraíba — UFPB, Campus I, João Pessoa, Paraíba CEP 5
3216 7003.
E-mail address: mrpiuvezam@ltf.ufpb.br (M.R. Piuve
1567-5769/$ – see front matter © 2013 Elsevier B.V. All
http://dx.doi.org/10.1016/j.intimp.2013.05.024a b s t r a c ta r t i c l e i n f oArticle history:
Received 18 March 2013
Received in revised form 27 May 2013
Accepted 28 May 2013
Available online 25 June 2013
Keywords:
Food allergy
Ovalbumin
Cissampelos sympodialis
Alkaloids
Cytokines
T cell populationsFood allergy is a severe human disease with imminent risk of life. Cissampelos sympodialis (Menispermaceae)
is a native Brazilian plant used in Brazilian folk medicine for the treatment of respiratory allergies. In this
study the experimental model of food allergy induced by ovalbumin (OVA) was used to determine whether
the alcoholic extract of the plant (AFL) and its alkaloids match a therapeutic approach for this disease. Animal
weight, diarrhea, OVA-speciﬁc IgE levels, inﬂammatory cell and cytokine proﬁles, mucus production and pro-
portion of T cells on the mesenteric lymph node (MLN) were evaluated. Warifteine (W) or methyl-warifteine
(MW) alkaloids slightly improve diarrhea score independently of AFL and all treatments decreased the
OVA-speciﬁc IgE levels. Stimulated mesenteric lymph node (MLN) cells in the presence of the alkaloids di-
minished the IL-12p70 levels independently of IFN-γ or IL-13 secretion. The alkaloids increased the number
of Treg cells on MLN and reduced the number of eosinophils and mast cells as well as mucus production in
the gut. Therefore, the alkaloids modulate the immune response in food allergy by increasing regulatory T
cells in MLN independently of Th1 or Th2 proﬁles.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Food allergy is an adverse health effect with intense diarrhea and
it is dependent on Th2 immune response. This disorder can occur re-
peatedly after an exposure to a given speciﬁc food allergen [1].There
is evidence of a high and increasing prevalence of food allergies all
over the world [2–4].
Increased health cost in ambulatory and emergency services be-
sides difﬁcult symptom control is described as important limitations
to food allergy treatments [5]. Besides, there is no effective therapy
and its management consists of changing patients' behavior, that is,
by asking them to avoid foods which may contain a given group of al-
lergens [1].This radical change in the behavior of allergic patients, as
well as in their family's, may lead to a poor quality of life and may re-
sult in nutritional deﬁciency and psychosocial distress [6,7].
The pathophysiology of food allergies is largely studied in murine
models, which present similarities with human food allergies [8]. In
these animal models, enhanced immunoglobulin-E (IgE) levels, inﬂam-
matory cell recruitment and Th2 cytokine secretions can be observed
[8–10].The IL-4, IL-5, IL-9 and IL-13 productions represent the Th2 pro-
ﬁle observed in allergies. These cytokines are involved in the speciﬁc IgEacologia, Universidade Federal
8051-900, Brazil. Tel.: +55 83
zam).
rights reserved.production, eosinophilia andmast cell activation. However, tomodulate
the process, the presence of regulatory T cells (Treg cells) into the mes-
enteric lymph nodes (MLN) has been described with the presence of
regulatory cytokines IL-10 and TGF-β [11,12]. Another regulatory cyto-
kine proﬁle observed in this disorder is from Th1 cells, mainly with
IFN-γ secretion.
Search for new therapies to treat food allergy has emerged and in
this perspective the medicinal plant extracts and isolated compounds
are being tested in food allergy models with promising results, rang-
ing from an attenuation of food allergy to an inhibition of the devel-
opment and progression of the disease [13,14].
Cissampelos sympodialis Eichl. (Menispermaceae) popularly named
“milona” is a plant used in the Northeastern Brazil to treat several in-
ﬂammatory diseases including allergic disorders. Studies from our
laboratory showed that the hydroalcoholic fraction from the leaves
(AFL) of the plant extract induced an anti-allergic cytokine proﬁle
with IL-10 and IFN-γ secretions by spleen cells [15–17]. In an exper-
imental model of asthma, AFL reduced IgE serum levels and leukocyte
recruitment to bronchoalveolar lavage [17–19]. Additionally, it was
demonstrated that AFL inhibited ERK and NF-κB expression in B cell
cultures [20].
In the perspective to describe which isolated compounds of AFL
were implicated in the anti-allergic effect, our group demonstrated
that warifteine, an alkaloid isolated from AFL, represents one of the bio-
active molecules. In a previous report it was showed that warifteine
inhibited IgE production, paw edema induced by ovalbumin (OVA),
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reaction induced by IgE-anti-DNP-OVA in rats [22]. Indeed, warifteine
inhibited histamine release ofmast cells after antigen challenge indicat-
ing that the alkaloid is one of the compounds in the plant extract with
an immunomodulatory effect [21].
Similarly to AFL, warifteine acts on B cell function by inhibiting cell
proliferation and Ig secretion, modifying the phosphorylation pattern
of mitogen-activated protein kinase (MAPK) ERK and the intracellular
levels of transcription factor NF-κB. Warifteine also attenuated the in-
tracellular calcium levels and increased the cAMP level in these cells
[20].
Given the knowledge about the plant effects in pulmonary allergy,
we postulate the hypothesis that the plant could also modulate food
allergy — an important public health problem all over the world.
Therefore, the aim of this study was to demonstrate the immunomod-
ulatory effect of the C. sympodialis extract, warifteine and its natural
methylated alkaloid, methyl-warifteine, in an experimental model
of food allergy.
2. Material and methods
2.1. Animals
Female BALB/c mice (20–25 g) and Wistar rats (250–300 g) were
used in the study. The animals were supplied by animal facility of
Federal University of Paraíba (UFPB/PB/Brazil). Experimental animals
were maintained with water and food ad libitum in a room tempera-
ture ranging from 22 to 24 °C and a 12 h light/dark cycle. Groups of
10 animals were used in each test. All experiments were carried out
with strict adherence to ethical guidelines and approved by the Ethi-
cal Committee for Experimental Animal/UFPB (CEPA No. 0302/11).
2.2. Plant extract and alkaloids
Leaves from C. sympodialiswere obtained from the Botanical Garden
of the Laboratory of Pharmaceutical Technology, UFPB (voucher speci-
men Agra 1456). The leaves were dried at 50 °C and pulverized. The
powder was extracted with 70% ethanol in water at 60 °C for 5 days.
The dried extract (AFL) was dissolved and ﬁltered in water. Known
volumes were dried to determine the ﬁnal concentration of the water-
soluble components (78% on average).The standardized AFL had a nom-
inal concentration of 0.95% of warifteine [19–21]. Alkaloid solutions
were prepared using 1 mg of the crystal in 50 μL of HCl 1 N and
800 μL of distilled water. The pH was adjusted to 7.0 with NaOH
1 N. The volume was completed to 1000 μL and the dilutions were
made in distilled water for the in vivo assay and in PBS for the in
vitro assay.
2.3. Murine food allergy and treatment
Experimentalmodel of food allergywas induced as brieﬂy described
and the schema is represented in Fig. 1. Micewere sensitized twice, two
weeks apart, with 50 μg of ovalbumin (OVA grade V, A-5503;Fig. 1. ExperimeSigma-Aldrich, St. Louis, Missouri, USA) in the presence of 1 mg of alu-
minum potassium sulfate adjuvant (alum, Sigma-Aldrich) by intraperi-
toneal injection. Twoweeks later, micewere held in the supine position
and an OVA solution (50 mg/250 μL) was orally administered. Before
each intragastric challenge and treatment, mice were deprived of food
for 3 h, and 1 h before each OVA-challenged animal was treated with
different drugs. Groups of animals (n = 10) were divided in: positive
control (CTR+, saline), AFL200 (AFL at 200 mg/kg), W2 (warifteine at
2 mg/kg), MW2 (methyl-warifteine at 2 mg/kg) or CROMO 10 (sodium
cromoglycate at 10 mg/kg) and the negative control (CTR−, non-
sensitized and OVA-challenged). Besides the CTR−, the other groups
were OVA-sensitized and OVA-challenged.Mice demonstrating profuse
liquid stool (diarrhea) were visually recorded for 60 min after chal-
lenges [22,23].
2.4. Body weight and diarrhea evaluation
The body weight of each group of animals was obtained from the
means of the individual values and expressed in grams (g). The gain
of weight to each animal in group was determined as:
% of weight gain ¼ animal weight on 50th day
animal weight on 28th day
−1
 
 100
and the percentage of body weight gain in each group was determined
by the means ± S.E.M. of % of weight gain and compared between
groups [24,25]. Diarrhea was deﬁned as diarrhea scores according to
feces appearance as follows: score 0 = no changes; score 1 = soft but
well formed; score 2 = soft, non-formed; score 3 = one episode of liq-
uid diarrhea; and score 4 = at least two episodes of liquid diarrhea. One
hour after the last challenge mice were sacriﬁced by exsanguination
under anesthesia and blood, mesenteric lymph nodes (MLN), and intes-
tinal tissue were taken for further analysis.
2.5. Determination of OVA-speciﬁc IgE titer
Brieﬂy, OVA-speciﬁc IgE titer was determined using the passive cu-
taneous anaphylaxis (PCA) reaction known as a reaction that is ex-
tremely precise to determine the antigen speciﬁc-IgE levels. Treated
and non-treated OVA-sensitized and non-sensitized groups were bled
and 50 μL of a serial dilution of each serumwas inoculated intradermal-
ly on the shaved back of Wistar rats at marked sites. After 24 h, the rats
were challenged intravenously with OVA (2.0 mg) in 1% Evans Blue
dye. Thirty minutes later the rats were euthanized and OVA-speciﬁc
IgE titers were measured. The highest serum dilution giving up to
5 mm diameter ﬂare or bluing reaction was taken as the PCA titer [26].
2.6. Cell preparation
Mesenteric lymph node cell suspensions from each animal group
were removed and processed in tissue grinder homogenizer. Cells
were washed twice in RPMI 1640 medium by centrifugation at
1200 rpm for 10 min at 4 °C. The pellet was resuspended in RPMIntal design.
Fig. 2. Effect of the plant extract and alkaloids on allergic diarrhea during ovalbumin
(OVA) challenges in OVA sensitized animals. OVA sensitized and treated mice were
OVA challenged ten times and before each challenge the animals were treated saline
(CTR+), plant extract (AFL 200 mg/kg), warifteine (W 2 mg/kg), methyl-warifteine
(MW 2 mg/kg) or sodium cromoglycate (CROMO 10 mg/kg) throughout the OVA
challenges. Negative control (CTR−) represents animals non-sensitized and
non-treated but challenged with OVA. Acute diarrhea occurrence was veriﬁed during
OVA challenges. Data were analyzed by ANOVA and the results are expressed as diar-
rhea score. *, signiﬁcantly different from CTR+ group (P ≤ 0.05). +, signiﬁcantly
different from the OVA-challenged group (P ≤ 0.05). Representative of three inde-
pendent experiments.
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lin, 100 μg/ml streptomycin, 5 μM β-mercaptoethanol and 10% fetal
calf serum (FCS — Gibco, Paisley, UK). Viable cells were determined in
a hemocytometer by the exclusion of the Trypan blue dye. Duplicate
cultures were performed in 24-well ﬂat-bottomed tissue culture plates
(Costar, Cambridge,MA, USA) in a ﬁnal volume of 1 mL/well containing
1 × 106 cells. Concanavalin-A (5 μg/mL) and warifteine or methyl-
warifteine at 0.1 or 1.0 μM were added in the cell cultures. The plate
was incubated for 12–48 h at 37 °C, 5% CO2. A volume of 900 μL of the
cell culture was removed and frozen at −20 °C for further cytokine
analysis [27].
2.7. Cytokine analysis
IL-12p70, IL-13 and IFN-γ in the supernatants of MLN cell cultures
were measured by ELISA, using the recommended protocol from the
antibodies' suppliers. Antibody pairs and standard recombinant cyto-
kines for ELISA assay were purchased from eBiosciences.
2.8. Flow cytometric analysis of mesenteric lymph node cells
Two aliquots of 1.0 × 106 MLN cells/3 mL of PBS (4 °C) from each
animal group were centrifuged (1200 rpm, 10 min, 4 °C) and the su-
pernatant was discarded. The cell suspensions were kept in PBS with
2 μL of mouse serum (1:100) for 5 min. One aliquot was used to
evaluate the amount of CD4+ and CD8+ T cells using monoclonal
antibodies: anti-mouse CD4-PE conjugated and CD8-FITC conjugated
purchased from eBiosciences. Another cell aliquot was evaluated for
the regulatory T cells using a kit from eBiosciences: anti-mouse CD4-
FITC conjugated, CD25-APC conjugated and FoxP3-PE conjugated.
After 30 min of incubation the cells were washed with 1 mL of PBS
(4 °C), centrifuged (1200 rpm, 10 min, 4 °C) and the pellet was
resuspended in 300 μL of PBS (4 °C). Cell analyzes were made by ﬂow
cytometry (BD Biosciences™, FACScalibur, San Jose, CA, USA) and Cell
Quest™ for Macintosh software (BD Biosciences™) was used to analyze
the data [28].
2.9. Gut histology
Gut segments (jejunum portion) were washed with cold saline,
ﬁxed with 4% buffered formalin and embedded in parafﬁn. 5-μm thick
gut sections were stained with Hematoxylin & Eosin (eosinophil
cells), Toluidine blue (mast cells) or periodic acid-Schiff (PAS) (mucus
production) according to standard protocols and were examined
under light microscopy. Analysis of tissue sections and captured images
were obtained at 40× (56 μm2/ﬁeld) using a computer-assisted image
analyzer (software AV soft Bio view (Spectra Module) version 4.0 for
Windows, Silver Spring, MD, USA). One observer who was unaware of
the experimental setting examined all tissue sections randomly. Digital
photographs of at least 10 sections per tissue (cross-sectional diameters
— 50 μm2) were obtained under light microscopy at ×400 magniﬁca-
tions. For quantifying eosinophil andmast cell inﬁltration of the gut tis-
sue, the total numbers of the cells were counted in ten areas, and the
mean was expressed as eosinophils or mast cells/high power ﬁeld
(HPF). Mucus secretion from goblet cells of the gut epithelium was
quantiﬁed by the staining of sections with PAS. For the determination
of goblet cell volume, all pixels with green hues were selected for the
creation of a binary image and subsequent calculation of the total
area, and the resulting data were reported as μm2 PAS/ﬁeld.
2.10. Statistical analyses
Data were analyzed by Student's t-test, ANOVA followed by Tukey
using software GraphPad Prism (GraphPad, San Diego, CA). Values
given are means ± S.E.M. A value of P b 0.05 was consideredsigniﬁcant. For ﬂow cytometry data analysis we used Win MDI soft-
ware (version 2.9, available at http://facs.scripps.edu/software.html).
3. Results
3.1. Effect of AFL or alkaloids on the body weight in murine food allergy
Treatment with the extract (AFL), warifteine (W), methyl-warifteine
(MW) or sodium cromoglycate (CROMO) was evaluated based on the
body weight loss caused by OVA challenges in mice. It was observed
that the mean body weight of treated animals from each experimental
group did not differ from one another during the OVA challenge period
(data not shown).
3.2. Effect of AFL or alkaloids treatment on the allergic diarrhea
Treatments with alkaloids (W and MW) slightly improved the diar-
rhea process similar to the pattern drug, sodium cromoglycate. Howev-
er, animals treated with the extract (AFL) did not show improvement
on the diarrhea process (Fig. 2). These results showed that the
anti-allergic properties of the alkaloids previously described in an asth-
ma model also prevented the diarrhea occurrence in this food allergic
model.
3.3. Effect of AFL or alkaloids treatment on IgE production
We also investigated the ability of the treatments in modulating the
production of OVA-speciﬁc IgE sera titer, a parameter related to severity
of immediate anaphylaxis hypersensitivity. As observed in Fig. 3, the
Fig. 3. Effect of the plant extract and alkaloids on ovalbumin-speciﬁc IgE titer. OVA sen-
sitized and treated mice were OVA challenged ten times and 1 h before each challenge
the animals were treated with saline (CTR+), plant extract (AFL 200 mg/kg),
warifteine (W 2 mg/kg), methyl-warifteine (MW 2 mg/kg) or sodium cromoglycate
(CROMO 10 mg/kg). The animals were bleeding after the tenth challenge for the col-
lection of serum. Non-sensitized mice (CTR−) did not present IgE serum titer (data
not shown). Data were analyzed by ANOVA followed by Dunnet and results are
expressed as the mean ± S.E.M. from at least ten animals. *, signiﬁcantly different
from the CTR+ group (P ≤ 0.05).+, signiﬁcantly different from the OVA-challenged
group (P ≤ 0.05). Representative of three independent experiments.
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cromoglycate (CROMO)were signiﬁcantly (P b 0.01) effective in decreas-
ing the amount of OVA-speciﬁc IgE serum levels (titers — 1:288 ± 52,Fig. 4. Effect of the alkaloids on cytokine release in mesenteric lymph node (MLN) cells of ov
Con-A (5 μg/mL) or medium only for 12 or 48 h. Supernatants were harvested and cytokine
were analyzed by ANOVA followed by Dunnet and results are expressed as the mean ± S.E.M
non-treated cells (medium) and *, P b 0.05 signiﬁcantly different compared with cells plus1:227 ± 117; 1:268 ± 78; 1:248 ± 65, respectively) as compared with
the non-treated group (CTR+, titer — 1:632 ± 65). Additionally,
non-sensitizedmice did not present IgE into the plasma. These results in-
dicate that the treatments are affecting the immune system response by
modulating B cells.
3.4. Effect of the alkaloids on the cytokine production
To identify the mechanisms by which warifteine or methyl-
warifteine treatment delayed diarrhea on the food allergy model, we
measured in vitro cytokine production in MLN cells from ovalbumin
sensitized mice. Con-A-stimulated cells produced, signiﬁcantly
(P b 0.05), IL-12p70, IFN-γ (Th1 proﬁle), and IL-13 (Th2 proﬁle) as
compared to non-stimulated cells (Fig. 4). In vitro treatment with
warifteine at 0.1 and 1 μM and methyl-warifteine at 1 μM inhibited
(P b 0.05) IL-12p70 production induced by Con-A (Fig. 4A) indepen-
dent of IFN-γ (Fig. 4B). However both alkaloids did not inhibit IL-13
production (Fig. 4C). The IL-12p70 modulation by the alkaloids indi-
cates that they are interfering with cells from the innate immune sys-
tem regardless if the cells from an adaptative immune system.
3.5. Effect of AFL or alkaloids on T cell proportion
In order to identify the T cell proﬁle of MNL of OVA-sensitized and
alkaloid-treated mice, ﬂow cytometry analyses were carried out. The
number of CD4+, CD8+ and CD25+Foxp3+ (regulatory T cells)
after OVA challenges was measured. Fig. 5A shows that the processalbumin sensitized mice. Mononuclear cells isolated from the MLN were cultured with
release was analyzed by ELISA assay. A. IL-12p70, B. IFN-γ and C. IL-13 in pg/mL. Data
. in three independent experiments. +, P b 0.05 signiﬁcantly different compared with
concanavalin-A (Con-A).
Fig. 5. Effect of the plant extract and alkaloids on CD4+ and CD8+ T cells frommesenteric lymph node (MLN) of ovalbumin sensitized mice. Proportion of CD4+ and CD8+ T cells
on the MNL was analyzed by ﬂow cytometry using monoclonal antibodies anti-CD4 PE and anti-CD8 FITC. A. Single cell suspensions of MLN stained for CD4+ and CD8+ cells and
analyzed by FACS. B. Percentage of CD4+ cells and (C) CD8+ cells from animal groups: negative control (CTR−), positive control (CTR+), plant extract (AFL 200), warifteine (W2),
methyl-warifteine (MW2) or sodium cromoglycate (CROMO10). Data were analyzed by Student's t-test and results are expressed as means ± S.E.M. in two similar independent
experiments. +P b 0.05, signiﬁcantly different compared with CTR+ group.
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reduced (P b 0.01) the percentage of CD4+ T cells in MLN as com-
pared with the non-sensitized group (CTR−) (38.9% vs 49.1% respec-
tively). AFL, W (P b 0.01) or MW (P b 0.05) treatments restored and
even increased the proportion of CD4+ T cells (48,2%; 51.1% and
43.8% respectively) as compared with CTR+ group (38.9%). The treat-
ment with sodium cromoglycate decreased the amount of CD4+ T
cells (39.6%) similar to the CTR+ group (38.9%).
Fig. 5A also showed that AFL, alkaloids (W, MW) or even sodium
cromoglycate treatments signiﬁcantly (P b 0.05, P b 0.01 and
P b 0.001) increased and restored the proportion of CD8+ T cells
(15.9%, 16.5%, 18.8 and 19.3%, respectively) as compared with CTR+
(13.3%) and CTR− (17.9%). Statistical analyses of the data showed in
Fig. 5A are plotted in column graphics as represented in Fig. 5B and C.
The proportion of CD25+FOXp3+ T cells among MLN cells is rep-
resented in Fig. 6A. MLN cells in the presence of the alkaloids (W or
MW) or extract (AFL) maintained and even increased the proportion
of CD25+FOXp3+ T cells (12.4%, 12.4% and 14.6% respectively) as
compared with the CTR+ group (11.8%). An interesting result ob-
served in this study was that the pattern drug treatment promoted
a profound reduction in this cell population (1.9%) as compared
with CTR+ group (11.8%). The amount of CD25+FOXp3+ T cells
into the CD4+ T population also was signiﬁcantly increased with
the treatments (Fig. 6B).
3.6. Effect of AFL and alkaloids in leukocyte inﬂux and mucus production
Stained gut tissue sections were analyzed to evaluate the effect of
AFL and alkaloid (W and MW) treatments on leukocyte recruitmentand mucus production. AFL and the alkaloids inhibited eosinophil re-
cruitment to the gut tissue compared to the CTR+ group (P ≤ 0.05)
(Fig. 7A, B). Both alkaloids also inhibited mast cell recruitment to
the gut tissue (P ≤ 0.05) (Fig. 8A, B) independent of the AFL. Howev-
er, AFL and the alkaloid treatments were able to inhibit mucus pro-
duction in the gut tissue (P ≤ 0.05) (Fig. 9A, B). Animals from the
control group did not present leukocytes or mucus production.
These data clearly demonstrated that the plant compounds are re-
sponsible for the anti- allergic property of the plant.4. Discussion
Food allergies are pathological conditions common in children and
adults justifying the development of therapeutic strategies to reverse
these conditions. Induction of oral tolerance by oral or sublingual
route, administration of allergenic molecules, clinically-tested drugs
or medicinal plants used in folk medicine can interfere with food al-
lergy symptoms such as diarrhea and loss of weight [8].
The oral antigen tolerance procedure can result in accidents with
drastic consequences such as anaphylactic shock reactions [29]. To
avoid severe side effects, a better regulation of the immune system
using plant extracts or even their compounds should be analyzed.
Studies with medicinal plants used in folk medicine to avoid allergic
symptoms have been addressed in different laboratories around the
world [30]. This perspective directed us to study the C. sympodialis extract
(AFL) and its alkaloidswarifteine andmethyl-warifteine in an experimen-
tal model of ovalbumin-induced food allergy [31]. These plant products
have been systematically studied and it has been shown that the plant
Fig. 6. Effect of the plant extract and alkaloids on regulatory T cells from mesenteric lymph node (MLN) of ovalbumin sensitized mice. The proportion of CD25, FoxP3 T cells on CD4
T cell population was analyzed by ﬂow cytometry using monoclonal antibodies anti-CD25 APC and anti-FoxP3 FITC. A. Single cell suspensions of MLN stained for CD25+ and Foxp3
cells and analyzed by FACS. Numbers represent the proportion of CD25+FoxP3+ cells among the CD4+ population from animal groups: negative control (CTR−), positive control
(CTR+), plant extract (AFL 200), warifteine (W2), methyl-warifteine (MW2) or sodium cromoglycate (CROMO10). B. Percentage of CD25+, FoxP3+, and CD4+ population into
the MLN cells. Data were analyzed by Student's t-test and results are expressed as means ± S.E.M. in two independent experiments. +, P b 0.05 signiﬁcantly different compared
with the CTR+ group.
Fig. 7. Effect of the plant extract and alkaloids on eosinophil recruitment to gut mucosa. Twenty-four hours after the last day of challenge, gut segments were ﬁxed in 4% formalin,
embedded in parafﬁn, and sectioned. Tissue section slides were stained with Hematoxylin & Eosin for eosinophil tissue evaluation. Different mice groups were analyzed: negative
control (CTR−), positive control (CTR+), plant extract (AFL 200), warifteine (W2) and methyl-warifteine (MW2).(A) Microscopic analysis of stained tissue sections. (B) Quanti-
tative analysis of tissue sections stained with Hematoxylin & Eosin.*P ≤ 0.05, signiﬁcantly different from the CTR+ group. +P ≤ 0.05, signiﬁcantly different from the
OVA-challenged group. Representative of three independent experiments.
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Fig. 8. Effect of theplant extract and alkaloids onmast cell recruitment to gutmucosa. Twenty-four hours after the last day of challenge, gut segmentswereﬁxed in4% formalin, embedded
in parafﬁn, and sectioned. Tissue section slides were stained with Toluidine blue for mast cell tissue evaluation. Different mice groups were analyzed: negative control (CTR−), positive
control (CTR+), plant extract (AFL 200), warifteine (W2) and methyl-warifteine (MW2). (A) Microscopic analysis of stained tissue sections. (B) Quantitative analysis of tissue sections
stained with Toluidine blue. *P ≤ 0.05, signiﬁcantly different from the CTR+ group. +P ≤ 0.05, signiﬁcantly different from the OVA-challenged group. Representative of three indepen-
dent experiments.
Fig. 9. Effect of the plant extract and alkaloids onmucus production. Twenty-four hours after the last day of challenge, gut segments were ﬁxed in 4% formalin, embedded in parafﬁn, and
sectioned. Tissue section slides were stained with PAS for mucus production tissue evaluation. Different mice groups were analyzed: negative control (CTR−), positive control (CTR+),
plant extract (AFL 200), warifteine (W2) and methyl-warifteine (MW2). (A) Microscopic analysis of stained tissue sections. (B) Quantitative analysis of tissue sections stained with PAS.
*P ≤ 0.05, signiﬁcantly different from the CTR+ group. +P ≤ 0.05, signiﬁcantly different from the OVA-challenged group. Representative of three independent experiments.
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an experimental model of asthma [15–21].
In this study AFL, warifteine or methyl-warifteine did not improve
the weight gain during OVA challenge procedures. However, these
treatments slightly decreased the allergic diarrhea process during
the OVA challenges demonstrating that the natural methylation of
warifteine did not improve its effect. This protective effect of the
treatments, mainly by the alkaloids, can be associated with inhibition
of mast and eosinophil cell activities. Indeed, a previous report dem-
onstrated that warifteine inhibited the hyperalgesia and scratching
behavior, which are both phenomena associated to mast cell degran-
ulation [21]. Interestingly AFL oral treatment showed no effect on the
allergic diarrhea process. However, all three treatments decreased the
amount of mucus on the goblet cells of the intestinal tissue.
The absence of a strong anti-diarrhea effect induced by the alka-
loids and the failure of the AFL treatment can be justiﬁed by a previ-
ous report on which the authors showed that AFL, warifteine or
methyl-warifteine inhibited phosphodiesterase (PDE) activity in in-
testinal smooth muscle and consequently increased cAMP levels.
cAMP is associated with an increased Ca2 channel activity whose re-
sult is the inﬂux of Na+ and H2O into the intestinal tract [32,33].
Therefore the slight anti-diarrhea effect of the compounds tested
may be justiﬁed based on the anti-immunoglobulin effect.
Antigen-speciﬁc IgE levels are induced in allergic mice after chal-
lenge procedure similar to what happens to humans [34,35]. Of
note, oral treatment with AFL or the alkaloids on this food allergy
model, one hour before each ovalbumin challenge, reduced the IgE
levels indicating a systemic protective effect. This phenomenon was
also observed in an experimental model of asthma and in B cell acti-
vation studies [16–20].
Previously, warifteine inhibited the phosphorylation of mitogen
activated protein kinase (MAPK) ERK1/2 and the intracellular levels
of the transcription factor κB (NF-kB) in activated B cells. In addition
warifteine increased cAMP levels in these cells. This phenomenon in-
hibits the phosphorylation of IκB required for the migration of NF-κB
to the cell nucleus and consequently inhibited B cell function [20,36].
Recently, we have been studding MAPK phosphorylation proﬁle in
mice peritoneal macrophages and, as preliminary results; we ob-
served that the methylated warifteine decreased the JNK phosphory-
lation in LPS-activated macrophages indicating the inhibition of
macrophage function (unpublished data).
Macrophages also have been studied as an immunomodulatory
target to C. sympodialis. Previous report showed that AFL treatment
decreased NO production and increased IL10 levels in T. cruzi infected
macrophages leading to proliferation of intracellular parasite [37].
These data indicated for the ﬁrst time that the plant presents com-
pounds that modulate macrophage function.
In order to study mechanisms of action of the alkaloids, Th1 and
Th2 cytokine proﬁles in the mesenteric lymph node cells from food
allergic mice were measured. In this study, both alkaloids inhibited
the IL-12p70 secretion on MLN cells stimulated by Con-A indepen-
dent of IFN-γ secretion.
According to data already publishedwith the plant extract and its al-
kaloids we suggest that in the experimental model of food allergy used
in this study, compounds of the plant are down regulating monocytes
and/or macrophages which represent the main sources of IL-12p70
probably without modifying T cell cytokine secretion. Indeed the treat-
ments did not alter IL-13 levels in Con-A stimulated MLN cell either.
To clarify this hypothesis we analyzed the proportion of CD4+,
CD8+ and Treg cells in the MLN of OVA-sensitized, -challenged mice
and treated them with alkaloids or the extract. The proportion of
CD4+ T or CD8+ T cells in MLN was restored to normal levels by AFL
or alkaloid treatments. Interestingly, we observed that the treatments
increased the proportion of Treg cells in the CD4+ T cell pool in the
MLN of mice. Treg cells are important in controlling a wide range of
immune-mediated pathologies including autoimmunity and allergies[38,39].The regulatory mechanism of Treg cells is related to the secre-
tion of IL-10 and/or TGF-β [40]. Therefore, further studies will be done
to explain this phenomenon.
Thus, we suggest that C. sympodialis (milona) used in the folk
medicine in Northeast Brazil modulates cells from the innate immu-
nity mainly, but also T regulatory cells in the experimental model of
food allergy. The data clearly showed that the treatments ameliorated
the disease symptoms. So, we postulate that the alkaloids from the
plant may be useful as adjuvant to improve treatments to food aller-
gic symptoms, however further studies should be addressed to dem-
onstrate the binding of these alkaloids to molecular targets.
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